Philippe Gallay

12.9k total citations · 1 hit paper
132 papers, 10.5k citations indexed

About

Philippe Gallay is a scholar working on Molecular Biology, Virology and Hepatology. According to data from OpenAlex, Philippe Gallay has authored 132 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 53 papers in Virology and 40 papers in Hepatology. Recurrent topics in Philippe Gallay's work include HIV Research and Treatment (53 papers), Signaling Pathways in Disease (50 papers) and Hepatitis C virus research (40 papers). Philippe Gallay is often cited by papers focused on HIV Research and Treatment (53 papers), Signaling Pathways in Disease (50 papers) and Hepatitis C virus research (40 papers). Philippe Gallay collaborates with scholars based in United States, Switzerland and Belgium. Philippe Gallay's co-authors include Didier Trono, Ulrike Blömer, Richard C. Mulligan, Daniel Ory, Fred H. Gage, Inder M. Verma, Luigi Naldini, Michael Bobardt, Udayan Chatterji and Didier Heumann and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Philippe Gallay

130 papers receiving 10.2k citations

Hit Papers

In Vivo Gene Delivery and Stable Transduction of Nondivid... 1996 2026 2006 2016 1996 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Gallay United States 44 5.6k 2.9k 2.7k 2.4k 2.2k 132 10.5k
Hongkui Deng China 58 8.5k 1.5× 1.5k 0.5× 3.9k 1.4× 3.4k 1.4× 1.3k 0.6× 170 16.0k
Pierre Charneau France 47 3.8k 0.7× 1.8k 0.6× 2.6k 1.0× 1.6k 0.7× 1.3k 0.6× 111 8.3k
Jeremy Luban United States 68 7.5k 1.3× 1.3k 0.5× 7.2k 2.6× 4.8k 2.0× 2.8k 1.2× 155 14.3k
Riccardo Cortese Italy 60 5.7k 1.0× 2.0k 0.7× 675 0.2× 1.4k 0.6× 2.9k 1.3× 144 11.1k
George N. Pavlakis United States 71 7.7k 1.4× 2.1k 0.7× 6.0k 2.2× 6.0k 2.5× 2.4k 1.1× 248 16.3k
Ara G. Hovanessian France 66 8.2k 1.5× 1.2k 0.4× 2.0k 0.7× 5.4k 2.3× 1.9k 0.8× 205 13.5k
John C. Kappes United States 54 4.0k 0.7× 1.1k 0.4× 8.8k 3.2× 4.7k 2.0× 2.7k 1.2× 163 13.8k
David Kabat United States 57 4.9k 0.9× 2.6k 0.9× 4.7k 1.7× 3.9k 1.6× 1.6k 0.7× 151 11.5k
John W. Schoggins United States 34 2.3k 0.4× 808 0.3× 878 0.3× 4.0k 1.6× 1.9k 0.8× 74 8.0k
Robert E. Lanford United States 56 4.1k 0.7× 1.1k 0.4× 713 0.3× 1.6k 0.7× 5.3k 2.4× 170 11.8k

Countries citing papers authored by Philippe Gallay

Since Specialization
Citations

This map shows the geographic impact of Philippe Gallay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Gallay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Gallay more than expected).

Fields of papers citing papers by Philippe Gallay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Gallay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Gallay. The network helps show where Philippe Gallay may publish in the future.

Co-authorship network of co-authors of Philippe Gallay

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Gallay. A scholar is included among the top collaborators of Philippe Gallay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Gallay. Philippe Gallay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallay, Philippe, et al.. (2024). Cyclophilin inhibition as a strategy for the treatment of human disease. Frontiers in Pharmacology. 15. 1417945–1417945. 6 indexed citations
2.
Paull, Jeremy Ra, Carolyn A. Luscombe, Graham P. Heery, et al.. (2024). Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium. Scientific Reports. 14(1). 21259–21259.
3.
Gallay, Philippe, Christina M. Ramirez, & Marc M. Baum. (2023). Acute antagonism in three-drug combinations for vaginal HIV prevention in humanized mice. Scientific Reports. 13(1). 4594–4594. 1 indexed citations
4.
Gunawardana, Manjula, Simon G. Webster, Paul Webster, et al.. (2022). Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis. Scientific Reports. 12(1). 8224–8224. 11 indexed citations
5.
Paull, Jeremy Ra, et al.. (2021). Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice. Viruses. 13(8). 1656–1656. 19 indexed citations
6.
Paull, Jeremy Ra, et al.. (2021). Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro. Antiviral Research. 191. 105089–105089. 27 indexed citations
7.
Gunawardana, Manjula, Simon G. Webster, Patricia Galván, et al.. (2020). Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis. Frontiers in Pharmacology. 11. 569373–569373. 19 indexed citations
8.
Gallay, Philippe, et al.. (2016). Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175. PLoS ONE. 11(4). e0152036–e0152036. 9 indexed citations
9.
Hopkins, Sam & Philippe Gallay. (2014). The role of immunophilins in viral infection. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(10). 2103–2110. 37 indexed citations
10.
Witte, Lot D. de, Michael Bobardt, Udayan Chatterji, et al.. (2007). Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proceedings of the National Academy of Sciences. 104(49). 19464–19469. 133 indexed citations
11.
Gallay, Philippe, et al.. (2005). Review of the twelfth West Coast retrovirus meeting. Retrovirology. 2(1). 72–72.
12.
Parseval, Aymeric de, Michael Bobardt, Anju Chatterji, et al.. (2005). A Highly Conserved Arginine in gp120 Governs HIV-1 Binding to Both Syndecans and CCR5 via Sulfated Motifs. Journal of Biological Chemistry. 280(47). 39493–39504. 76 indexed citations
13.
Gallay, Philippe. (2004). Syndecans and HIV-1 pathogenesis. Microbes and Infection. 6(6). 617–622. 45 indexed citations
14.
Heumann, Didier, S. Bas, Philippe Gallay, et al.. (1995). Lipopolysaccharide binding protein as a marker of inflammation in synovial fluid of patients with arthritis: correlation with interleukin 6 and C-reactive protein.. PubMed. 22(7). 1224–9. 29 indexed citations
15.
Heumann, Didier, et al.. (1995). Contribution of lipopolysaccharide binding protein (LBP) in endotoxemic shock in mice.. PubMed. 392. 465–71. 1 indexed citations
16.
Gallay, Philippe, Simon Swingler, Christopher Aiken, & Didier Trono. (1995). HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80(3). 379–388. 272 indexed citations
17.
Gallay, Philippe, Simon Swingler, Jinping Song, Frederic D. Bushman, & Didier Trono. (1995). HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 83(4). 569–576. 304 indexed citations
18.
Heumann, Didier, et al.. (1994). Radioimmunoassay versus flow cytometric assay to quantify LPS-binding protein (LBP) concentrations in human plasma. Journal of Immunological Methods. 171(2). 169–176. 7 indexed citations
19.
Corradin, Sally Betz, et al.. (1994). Bactericidal/Permeability-Increasing Protein Inhibits Induction of Macrophage Nitric Oxide Production by Lipopolysaccharide. The Journal of Infectious Diseases. 169(1). 105–111. 25 indexed citations
20.
Carrel, S, et al.. (1991). Positive signal transduction via surface CD4 molecules does not need coexpression of the CD3/TcR complex. Research in Immunology. 142(2). 97–108. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026